RNA interference: Biogenesis molecular mechanisms and its applications in cervical cancer;RNA de interferencia: Biogénesis, mecanismos moleculares y sus aplicaciones en cáncer cervical

Revista de Investigacion Clinica

Volumn 62, Issue 1, 2010, Pages 63-80

  Peralta Zaragoza, Oscar ^a   Bermúdez Morales, Víctor Hugo ^a   Madrid Marina, Vicente ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Cervical cancer; E6 and E7 oncogenes; HPV; MicroRNA; RNAi, siRNA

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA;

APOPTOSIS; BIOGENESIS; BIOLOGICAL ACTIVITY; CANCER INHIBITION; CELL IMMORTALIZATION; CELL TRANSFORMATION; DNA CLEAVAGE; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; HUMAN; REVIEW; RNA INTERFERENCE; TRANSLATION REGULATION; UTERINE CERVIX CANCER; VIRUS ONCOGENE; VIRUS ONCOGENE E6; VIRUS ONCOGENE E7; WART VIRUS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, VIRAL; COMBINED MODALITY THERAPY; DRUG DESIGN; FEMALE; GAMMAPAPILLOMAVIRUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; HUMANS; MICRORNAS; ONCOGENE PROTEINS, VIRAL; ONCOGENES; PAPILLOMAVIRUS INFECTIONS; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TELOMERASE; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 77952181555     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Napoli C, Lemieux C, Jorgensen R. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell 1990; 2: 279-289 (Pubitemid 120029588)
2. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811 (Pubitemid 28099681)
3. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev 2003; 17: 438-442
4. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858 (Pubitemid 33032103)
5. Lau NC, Lim LP, Weinstein EG, Battel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294: 858-862
6. Lee RC, Ambras V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294: 862-864
7. Tijsterman M, Ketting RF, Plasterk RH. The genetics of RNA silencing. Annu Rev Genet 2002; 36: 489-519.
8. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002; 2: 342-350.
9. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19. (Pubitemid 29406813)
10. Bermúdez-Morales V, Peralta-Zaragoza O, Madrid-Marina V. Gene therapy with cytokines against cervical cancer. Revista Salud Pública de México 2005; 47: 458-468 (Pubitemid 43187097)
11. Zheng YF, Rao ZG, Zhang JR. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi. Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 496-498
12. Choo CK, Ling MT, Suen CK, Chan KW, Kwong YL. Retrovirus-mediated delivery of HPV 16 E7 antisense RNA inhibited tumori-genicity of CaSki cells. Gynecol Oncol 2000; 78: 293-301.
13. Storey A, Oates D, Banks L, Crawford L, Crook T. Anti-sense phosphorothioate oligonucleotides have both specific and nonspecific effects on cells containing human papillomavirus type 16. Nucleic Acids Res 1991; 19: 4109-4114 (Pubitemid 21912780)
14. Elbashir SM, Harborfh J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498
15. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001; 20: 6877-6888 (Pubitemid 33134217)
16. Bartel PD. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 2004; 116: 281-297
17. Johnson SM, Lin SY, Slack FJ. The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Dev Biol 2003; 259: 364.79.
18. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T (2003). New microRNAs from mouse and human. RNA 2003; 9: 175-179
19. Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-235
20. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-240 (Pubitemid 39545855)
21. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes and Development. 2004; 18: 3016-3027
22. Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster ho-molog are required for miRNA biogenesis. Current Biology. 2004; 14: 2162-2167 (Pubitemid 39623200)
23. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966 (Pubitemid 39557833)
24. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425: 415-419 (Pubitemid 37187272)
25. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO Journal 2002; 21: 4663-4670 (Pubitemid 34984353)
26. Brownawell AM, Macara IG. Exportin-5, a novel karyo-pherin, mediates nuclear export of double-stranded RNA binding proteins. J Cell Biology 2002; 156: 53-64.
27. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes and Development 2003; 17: 3011-3016 (Pubitemid 38040764)
28. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004; 10: 185-191 (Pubitemid 38129823)
29. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303: 95-98
30. Knight SW, Bass BL. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 2001; 293: 2269-2271
31. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 2001; 15: 2654-2659 (Pubitemid 32988876)
32. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-366 (Pubitemid 32151243)
33. Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002; 21: 5864-5874 (Pubitemid 35315284)
34. Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002; 21: 5875-5885 (Pubitemid 35315285)
35. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells, Nature 2000; 404: 293-296 (Pubitemid 30163547)
36. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123: 631-640 (Pubitemid 41608466)
37. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi, Cell 2002; 110: 563-574 (Pubitemid 35247837)
38. Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway, Cell 2001; 107: 309-321 (Pubitemid 33049975)
39. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293: 1146-1150 (Pubitemid 32758097)
40. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 2000; 16: 720-728 (Pubitemid 34274041)
41. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002; 297: 2056-2060
42. Pham JW, Pellino JL, Lee YS, Carthew RW, Sontheimer EJ. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell 2004; 117: 83-94.
43. Sontheimer EJ. Assembly and function of RNA silencing complexes, Nat Rev Mol Cell Biol 2005; 6: 127-138 (Pubitemid 40215808)
44. Filipowicz W. RNAi: the nuts and bolts of the RISC machine. Cell 2005; 122: 17-20. (Pubitemid 40977936)
45. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ et al. Argonaute 2 is the catalytic engine of mammalian RNAi. Science 2004; 305: 1437-1441 (Pubitemid 39167657)
46. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004; 15: 185-197 (Pubitemid 38950966)
47. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. Crystal structure of Argonaute and its implications for RISC sheer activity. Science 2004; 305: 1434-1437 (Pubitemid 39167656)
48. Ma JB, Yuan YR, Meister G, Pei Y, Tuschl T, Patel DJ. Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein, Nature 2005; 434: 666-670 (Pubitemid 40488561)
49. Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu J, Hannon GJ, Joshua-Tor L. Purified Argonaute 2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 2005; 12: 340-349
50. Haley B, Zamore PD. Kinetic analysis of the RNAi enzyme complex, Nat Struct Mol Biol 2004; 11: 599-606. (Pubitemid 38823525)
51. Okamura K, Ishizuka A, Siomi H, Siomi MC. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways, Genes Dev 2004; 18: 1655-1666 (Pubitemid 38938183)
52. Jiang F, Ye X, Liu X, Fincher L, McKearin D, Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev 2005; 19: 1674-1679 (Pubitemid 41058362)
53. Saito K, Ishizuka A, Siomi H, Siomi MC. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol 2005; 3: 1202-1212 (Pubitemid 41032188)
54. Tabara H, Yigit E, Siomi H, Mello CC. The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans. Cell 2002; 109: 861-871
55. Tahbaz N, KoLb FA, Zhang H, Jaronczyk K, Filipowicz W, Hobman TC. Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer. EMBO Rep 2004; 5: 189-194
56. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740-744
57. Liu Q, Rand TA, Kalidas S, Du F, Kim HE, Smith DP, Wang X, R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 2003; 301: 1921-1925 (Pubitemid 37221400)
58. Grishok A, Tabara H, Mello CC. Genetic requirements for inheritance of RNAi in C. elegans. Science 2000; 287: 2494-2497 (Pubitemid 30185446)
59. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 2001; 106: 23-34. (Pubitemid 32709955)
60. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD. A protein sensor for siRNA asymmetry. Science 2004; 306: 1377-1380 (Pubitemid 39532515)
61. Zhang H, KoLb FA, Jaskiewicz L, Westhof E, Filipowicz W. Single processing center models for human Dicer and bacterial RNase III. Cell 2004; 118: 57-68. (Pubitemid 38902814)
62. Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, Saigo K. Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors. Curr Biol 2003; 13: 41-46 (Pubitemid 36080621)
63. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004; 117: 69-81. (Pubitemid 38469899)
64. Ghildiyal M, Seitz H, Horwich MD, Li C, Du T, Lee S, et al. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science 2008; 320(5879): 1077-1081 (Pubitemid 351929549)
65. Czech B, Malone CD, Zhou R, Stark A, Schlingeheyde C, Dus M, Perrimon N, et al. An endogenous small interfering RNA pathway in Drosophila. Nature 2008; 453(7196): 798-802. (Pubitemid 351793787)
66. Okamura K, Chung WJ, Ruby JG, Guo H, Bartel DP, Lai EC. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature 2008; 453(7196): 803-806 (Pubitemid 351793790)
67. Kawamura Y, Saito K, Kin T, Ono Y, Asai K, Sunohara T, Okada TN, Siomi MC, Siomi H. Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells. Nature 2008; 453(7196): 793-797 (Pubitemid 351793781)
68. Okamura K, Balla S, Martin R, Liu N, Lai EC. Two distinct mechanisms generate endogenous siRNAs from bidirectional transcription in Drosophila melanogaster. Nature Struct Mol Biol 2008; 15: 581-590 (Pubitemid 351799142)
69. Chung WJ, Okamura K, Martin R, Lai EC. Endogenous RNA interference provides a somatic defense against Drosophila transposons. Curr Biol 2008; 18: 795-802.
70. Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, Timmons L, et al. The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 1999; 99(2): 123-132
71. Ketting RF, Haverkarrip TH, van Luenen HG, Plasterk RH. Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 1999: 99; 133-141
72. Zhou R, Hotta I, Denli AM, Hong P, Perrimon N, Hannon GJ. Comparative analysis of argonaute-dependent small RNA pathways in Drosophila. Mol Cell 2008; 32(4): 592-599
73. Förstemann K, Tomari Y, Du T, Vagin VV, Denli AM, Bratu DP, Kiattenhoff C, Theurkauf WE, Zamore PD. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol 2005; 3(7): 1187-1201 (Pubitemid 41032187)
74. Yang N, Kazazian HHJ. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nature Struct Mol Bio 2006; 13: 763-771 (Pubitemid 44338769)
75. Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453(7194): 534-538 (Pubitemid 351733314)
76. Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata Y, et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 2008; 453(7194): 539-543
77. Sasidharan R, Gerstein M. Genomics: protein fossils live on as RNA. Nature 2008; 453: 729-731 (Pubitemid 351793770)
78. Yoshinari K, Miyagishi M, Taira K. Effectson RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acid Res 2004; 32: 691-699 (Pubitemid 38263060)
79. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209-216 (Pubitemid 37329584)
80. Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199-208. (Pubitemid 37329583)
81. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330
82. Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 2004; 32: 936-948
83. Sioud M, Sorensen DR. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 2003; 312: 1220-1225 (Pubitemid 37490947)
84. Zhang X, Shan P, Jiang D, Noble PW, Abraham NG, Kappas A, Lee PJ. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004; 279: 10677-10684 (Pubitemid 38372680)
85. Liu C, Shi Y, Han Z, Pan Y, Liu N, Han S, et al. Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 transactivation and increases expression of EPO. Biochem Biophys Res Commun 2003; 312: 780-786 (Pubitemid 37468239)
86. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553 (Pubitemid 34408678)
87. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 5515-5520
88. Pinkenburg O, Platz J, Beisswenger C, Vogelmeier C, Bals R. Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus. J Virol Meth 2004; 120: 119-122 (Pubitemid 38968663)
89. Sanchez-Vargas I, Travanty EA, Keene KM, Franz AW, Beaty BJ, Blair CD, Olson AE. RNA interference, arthropod-borne viruses, and mosquitoes. Virus Res 2004; 102: 65-74. (Pubitemid 38447251)
90. An DS, Xie Y, Mao SH, Morizono K, Kung SJ, Chen IS, Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther 2003; 14: 1207-1212
91. Lee JS, Hmama Z, Mui A, Reiner NE. Stable gene silencing in human monocytic cell lines using lentiviral-delivered small interference RNA. Silencing of the p110alpha isoform of phosphoinositide 3-kinase reveals differential regulation of adherence induced by 1alpha, 25- dihydroxycholecalciferol and bacterial lipopolysaccharide. J Biol Chem 2004; 279: 9379-9388 (Pubitemid 38296003)
92. Li MJ, Rossi JJ, Lentiviral vector delivery of recombinant small interfering RNA expression cassettes. Meth Enzymol 2005; 392: 218-226 (Pubitemid 40092517)
93. Futami T, Miyagishi M, Seki M, Taira K. Induction of apoptosis in HeLa cells with siRNA expression vector targeted against bcl-2. Nucl Acids Res Suppl 2002; 2: 251-252
94. Matsukura S, Jones PA, Takai D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 2003; 31: 77-81.
95. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4: 609-615 (Pubitemid 36939953)
96. de Felipe P, Izquierdo M. Tricistronic and tetracistronic retroviral vectors for gene transfer. Hum Gene Ther 2000; 11: 1921-1931
97. Devroe E, Silver PA. Retrovirus-delivered siRNA. BMC Biotechnol. 2002; 2: 15-20.
98. Freytag SO, Khil M, Strieker H, Peabody J, Menon M, DePeralta-Venturina M, et al. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res 2002; 62: 4968-4976
99. Carette JE, Overmeer RM, Schagen FH, Alemany R, Barski OA, Gerritsen WR, Van Beusechem VW. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res 2004; 64: 2663-2667 (Pubitemid 38500597)
100. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003; 9: 1539-1544 (Pubitemid 38004783)
101. Van den Haute C, Eggermont K, Nuttin B, Debyser Z, Baekelandt V. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum Gene Ther 2003; 14: 1799-1807
102. Kjaer SK, van den Brule AJC, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk Human Papillomavirus (HPV) as indicator of high grade cervical squamous intreapithelial lesions in young women: population based prospective follow up study. BMJ 2002; 325: 1-7.
103. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92(9): 690-698
104. Wise-Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 2008; 13: 1003-1017
105. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10(4): 431-442
106. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8(4): 275-283
107. Dick FA, Dyson NJ. Three regions of the pRb pocket domain affect its inactivation by human papillomavirus E7 proteins. J Virol 2002; 76: 6224-6234
108. Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors. EMBO J 1996; 15: 1950-1960 (Pubitemid 26119228)
109. Veldman T, Liu X, Yuan H, Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci USA 2003; 100: 8211-8216 (Pubitemid 36842524)
110. Yukawa K, Butz K, Yasui T, Kikutani H, Hoppe-Seyler F. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-la. J Virol 1996; 70: 10-16.
111. Cho NH, Kim YT, Kim JW. Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors. Yonsei Med J 2002; 436: 722-728
112. Phillips AC, Vousden KH. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP. J Gen Virol 1997; 78: 905-909
113. Maldonado E, Cabrejos ME, Banks L, Allende JE. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor. J Cell Biochem 2002; 85(4): 663-669 (Pubitemid 34462777)
114. Desaintes C, Hallez S, Van Alphen P, Burny A. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 1992; 66: 325-333
115. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. Papillomavirus type 16 oncogenes downregulate expression of interferon- responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol 2001; 75: 4283-4296 (Pubitemid 32410141)
116. Peralta-Zaragoza O, Bermúdez-Morales VH, Gutiérrez- Xicotencatl L, Alcocer-González JM, Recillas-Targa F, Madrid-Marina V. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta-1 promoter throughout Sp1 regulatory element. Viral Immunology 2006; 19: 468-480
117. Halbert CL, Demers GW, Galloway DA. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 1992; 66: 2125-2134
118. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213-228 (Pubitemid 35351540)
119. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002; 21: 6041-6048
120. Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y, et al. In vitro and in ivo Growth Suppression of Human Papillomavirus 16-Positive Cervical Cancer Cells by E6 siRNA. Molecular Therapy 2003; 8: 762-768
121. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003; 22: 5938-5945 (Pubitemid 37175872)
122. Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD, Muller CY. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Reprod Sci. 2007; 14: 20-28. (Pubitemid 351168772)
123. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci USA 2000; 97: 6693-6697 (Pubitemid 30412776)
124. Koivusalo R, Krausz E, Helenius H, Hietanen S. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA mediated degradation of human papillomavirus 18 E6 mRNA: Opposite effect of siRNA in combination with different drugs. Mol Pharmacol 2005; 68: 372-382 (Pubitemid 41058301)
125. Putral LN, By water MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol Pharmacol 2005; 68: 1311-1319
126. Niu XY, Peng ZL, Duan WQ, Wang H, Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int J Gynecol Cancer 2006; 16: 743-751 (Pubitemid 43155929)
127. Jiang M, Rubbi CP, Milner J. Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis. Oligonucleotides 2004; 14: 239-248 (Pubitemid 40144362)
128. Takuma F, Miyuki S, Eri I, Takahiro O, Yoshifumi T, Shigenori H, et al. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Int J Oncology 2006; 29: 541-548
129. Gu W, Putral L, McMillan N. siRNA and shRNA as anticancer agents in a cervical cancer model. Methods Mol Biol 2008; 442: 159-172
130. Naldini L, Verma IM. Lentiviral vectors. Adv Virus Res 2000: 55; 599-609.
131. Wang R, Lin F, Wang X, Gao P, Dong K, Wei SH, et al. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Cancer Biol Ther 2007; 6(8): 1295-1301 (Pubitemid 351590386)
132. Zaffaroni N, Pennati M, Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med 2005; 9(2): 360-372
133. Kuner R, Vogt M, Suitmann H, Buness A, Dymalla S, Bulkescher J, et al. Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses. J Mol Med. 2007; 85: 1253-1262 (Pubitemid 47622224)
134. Naito Y, Yamada T, Ui-Tei K, Morishita S, Saigo K. siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. Nucleic Acids Res 2004; 32: 124-129 (Pubitemid 38997313)
135. Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, et al. New highly potent and specific E6 and E7 siRNAs for treatment of HPV 16 positive cervical cancer. Cancer Gene Therapy 2008; 15: 140-153 (Pubitemid 351240669)
136. http://www.ambion.com/techlib/misc/siRNA-finder.html.
137. Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, et al. RNA interference against HPV 16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis 2008; 13: 273-281